Seong-Ho Ok1,2, Ju-Tae Sohn3,2. 1. Department of Anesthesiology and Pain Medicine, Gyeongsang National University Changwon Hospital, Changwon, Korea. 2. Institute of Health Sciences, Gyeongsang National University, Jinju, Korea. 3. Department of Anesthesiology and Pain Medicine, Gyeongsang National University Hospital, Gyeongsnag National University School of Medicine, Jinju, Korea.
We read the interesting article ‘Amlodipinetoxicity complicated by concurrent medications’ in the Korean Journal of Anesthesiology [1]. In addition to the supportive treatment of amlodipinetoxicity reported by Gupta and Kerai [1], the following should be considered in the treatment and interpretation of this case. First, amlodipine is a dihydropyridine L-type calcium channel blocker and mainly produces vasodilation in the treatment of hypertension [2]. Toxic doses of amlodipine produce not only vasodilation but also severe cardiac depression [2]. It has been reported that lipid emulsion alleviates the severe cardiovascular depression induced by toxic doses of amlodipine [2-4]. In addition, the widely accepted underlying mechanism associated with lipid emulsion-mediated treatment of local anesthetic toxicity is a scavenging effect (lipid sink and shuttle), in which a drug with high lipid solubility is absorbed into a lipid emulsion of plasma from tissue and then transported into the liver and muscle for detoxification [5]. Moreover, lipid emulsion alone causes a direct inotropic effect [5]. Taking into consideration the above comments, as amlodipine is highly lipid soluble (log [octanol/water partition coefficient]: 3.0) and a toxic dose of amlodipine additionally produces myocardial depression, lipid emulsion treatment should be considered for the treatment of cardiovascular depression induced by a toxic dose of amlodipine [2,5]. Second, Gupta and Kerai [1] emphasized successful treatment of amlodipinetoxicity complicated by concurrent medication. Following a suicide attempt using a specific drug, additional agents other than the drug used in the attempt are concurrently administered in some cases of drug toxicity. In some cases of amlodipinetoxicity with other concurrent medication (ethanol, simvastatin, and trazodone), as in this case report, lipid emulsion treatment partially contributes to recovery from cardiovascular depression induced by a toxic dose of amlodipine [2,4]. We believe that timely treatment including activated charcoal and supportive care in this case also contributed to recovery from amlodipine-induced cardiovascular depression.
Authors: Seong-Ho Ok; Soo Hee Lee; Ji-Yoon Kim; Hyun-Jin Kim; Sung Il Bae; Yeran Hwang; Seongyeong Tak; Ju-Tae Sohn Journal: Int J Med Sci Date: 2019-11-09 Impact factor: 3.738